Efficacy and safety of turoctocog alfa in patients with hemophilia A requiring surgical procedures: A multicentre retrospective study.

Nicolas DrillaudVincent CussacPierre-Olivier BerthoValérie HorvaisPhilippe BeurrierCatherine TernisienJohann RoseMarc FouassierAntoine BabutyMarc Trossaërt

Published in: Transfusion (2023)

The efficacy and safety of turoctocog alfa were confirmed for the management of surgery in patients with hemophilia A. No adverse events were observed and overall efficacy was good.

Keyphrases

replacement therapy
minimally invasive
coronary artery bypass
clinical trial
study protocol
surgical site infection
cross sectional
double blind
randomized controlled trial
atrial fibrillation